ID   XRN2_CAEEL              Reviewed;         975 AA.
AC   Q9U299;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   05-DEC-2018, entry version 127.
DE   RecName: Full=5'-3' exoribonuclease 2 homolog;
DE            EC=3.1.13.- {ECO:0000269|PubMed:19734881, ECO:0000269|PubMed:24462208, ECO:0000269|PubMed:26779609};
GN   Name=xrn-2 {ECO:0000312|WormBase:Y48B6A.3};
GN   ORFNames=Y48B6A.3 {ECO:0000312|WormBase:Y48B6A.3};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, INDUCTION, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=16122351; DOI=10.1371/journal.pbio.0030312;
RA   Frand A.R., Russel S., Ruvkun G.;
RT   "Functional genomic analysis of C. elegans molting.";
RL   PLoS Biol. 3:E312-E312(2005).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=19734881; DOI=10.1038/nature08349;
RA   Chatterjee S., Grosshans H.;
RT   "Active turnover modulates mature microRNA activity in Caenorhabditis
RT   elegans.";
RL   Nature 461:546-549(2009).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=21397849; DOI=10.1016/j.devcel.2011.02.008;
RA   Chatterjee S., Fasler M., Bussing I., Grosshans H.;
RT   "Target-mediated protection of endogenous microRNAs in C. elegans.";
RL   Dev. Cell 20:388-396(2011).
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=23541767; DOI=10.1016/j.molcel.2013.02.023;
RA   Bosse G.D., Ruegger S., Ow M.C., Vasquez-Rifo A., Rondeau E.L.,
RA   Ambros V.R., Grosshans H., Simard M.J.;
RT   "The decapping scavenger enzyme DCS-1 controls microRNA levels in
RT   Caenorhabditis elegans.";
RL   Mol. Cell 50:281-287(2013).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH PAXT-1, DEVELOPMENTAL
RP   STAGE, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF 234-ASP--ASP-236.
RX   PubMed=24462208; DOI=10.1016/j.molcel.2014.01.001;
RA   Miki T.S., Richter H., Rueegger S., Grosshans H.;
RT   "PAXT-1 promotes XRN2 activity by stabilizing it through a conserved
RT   domain.";
RL   Mol. Cell 53:351-360(2014).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.84 ANGSTROMS) OF 1-787 IN COMPLEX WITH
RP   PAXT-1, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=26779609; DOI=10.1038/nsmb.3155;
RA   Richter H., Katic I., Gut H., Grosshans H.;
RT   "Structural basis and function of XRN2 binding by XTB domains.";
RL   Nat. Struct. Mol. Biol. 23:164-171(2016).
CC   -!- FUNCTION: Possesses 5'->3' exoribonuclease activity
CC       (PubMed:19734881, PubMed:21397849). Plays a role in maintenance of
CC       steady-state concentration and turnover of microRNAs (miRNA) by
CC       degradation of mature miRNA (PubMed:19734881, PubMed:21397849,
CC       PubMed:26779609). Degradation role is enhanced when in complex
CC       with paxt-1 (PubMed:24462208, PubMed:26779609). Partially
CC       redundant to xrn-1 in miRNA guide strand degradation
CC       (PubMed:19734881, PubMed:21397849). Implicated in differential
CC       regulation of mRNAs such as let-7 by controlling the accumulation
CC       of mature miRNA (PubMed:19734881, PubMed:21397849). Positively
CC       regulates molting of the pharyngeal cuticle (PubMed:16122351,
CC       PubMed:19734881). {ECO:0000269|PubMed:16122351,
CC       ECO:0000269|PubMed:19734881, ECO:0000269|PubMed:21397849,
CC       ECO:0000269|PubMed:24462208, ECO:0000269|PubMed:26779609}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.3913 uM for FAM fluorophore-coupled RNA substrate and a
CC         quencher-coupled DNA primer {ECO:0000269|PubMed:26779609};
CC         Vmax=0.000197 umol/sec/ug enzyme {ECO:0000269|PubMed:26779609};
CC   -!- SUBUNIT: Interacts with paxt-1 (via N-terminus); the interaction
CC       is direct and results in stabilization of xrn-2 in the complex.
CC       {ECO:0000269|PubMed:24462208, ECO:0000269|PubMed:26779609}.
CC   -!- INTERACTION:
CC       Q21738:paxt-1; NbExp=5; IntAct=EBI-320499, EBI-11705385;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:23541767}.
CC   -!- TISSUE SPECIFICITY: Expressed in the pharyngeal myoepithelium and
CC       intestine. Also expressed in several anterior neurons including
CC       the sensory neurons, as well as the interneuron PVT and the
CC       pharyngeal motorneuron M5. {ECO:0000269|PubMed:16122351}.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout all developmental
CC       stages. Detected in the M5 pharyngeal neuron only in larvae. Also
CC       persistently expressed in the intestine of adults past the molting
CC       stage. {ECO:0000269|PubMed:16122351, ECO:0000269|PubMed:24462208}.
CC   -!- INDUCTION: Up-regulated prior to molting.
CC       {ECO:0000269|PubMed:16122351}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown results in impaired
CC       miRNA degradation leading to accumulation of mature miRNA
CC       passenger (miR*) strands (PubMed:19734881, PubMed:21397849).
CC       Defective molting owing to failure to shed cuticle from the
CC       pharynx in the late L4-stage larvae (PubMed:16122351). Suppresses
CC       the vulval bursting phenotype of let-7 mutant (PubMed:19734881).
CC       Reduced paxt-1 expression (PubMed:24462208).
CC       {ECO:0000269|PubMed:16122351, ECO:0000269|PubMed:19734881,
CC       ECO:0000269|PubMed:21397849, ECO:0000269|PubMed:24462208}.
CC   -!- SIMILARITY: Belongs to the 5'-3' exonuclease family. XRN2/RAT1
CC       subfamily. {ECO:0000305}.
DR   EMBL; AL110490; CAB54449.2; -; Genomic_DNA.
DR   PIR; T27005; T27005.
DR   RefSeq; NP_496958.2; NM_064557.5.
DR   UniGene; Cel.14046; -.
DR   PDB; 5FIR; X-ray; 2.84 A; A/C/E/G/I/K=1-787.
DR   PDBsum; 5FIR; -.
DR   ProteinModelPortal; Q9U299; -.
DR   SMR; Q9U299; -.
DR   BioGrid; 40353; 1.
DR   ComplexPortal; CPX-420; xtbd-paxt-1 complex.
DR   DIP; DIP-24636N; -.
DR   IntAct; Q9U299; 3.
DR   STRING; 6239.Y48B6A.3.1; -.
DR   EPD; Q9U299; -.
DR   PaxDb; Q9U299; -.
DR   PeptideAtlas; Q9U299; -.
DR   PRIDE; Q9U299; -.
DR   EnsemblMetazoa; Y48B6A.3; Y48B6A.3; WBGene00006964.
DR   GeneID; 175071; -.
DR   KEGG; cel:CELE_Y48B6A.3; -.
DR   UCSC; Y48B6A.3; c. elegans.
DR   CTD; 175071; -.
DR   WormBase; Y48B6A.3; CE42702; WBGene00006964; xrn-2.
DR   eggNOG; KOG2044; Eukaryota.
DR   eggNOG; COG5049; LUCA.
DR   GeneTree; ENSGT00670000098098; -.
DR   HOGENOM; HOG000205514; -.
DR   InParanoid; Q9U299; -.
DR   KO; K12619; -.
DR   OMA; GEHFDSN; -.
DR   OrthoDB; EOG091G00A4; -.
DR   PhylomeDB; Q9U299; -.
DR   SABIO-RK; Q9U299; -.
DR   PRO; PR:Q9U299; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00006964; Expressed in 5 organ(s), highest expression level in multi-cellular organism.
DR   GO; GO:0005730; C:nucleolus; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:WormBase.
DR   GO; GO:0008409; F:5'-3' exonuclease activity; ISS:UniProtKB.
DR   GO; GO:0004534; F:5'-3' exoribonuclease activity; IDA:WormBase.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0000738; P:DNA catabolic process, exonucleolytic; ISS:UniProtKB.
DR   GO; GO:0006353; P:DNA-templated transcription, termination; IEA:UniProtKB-KW.
DR   GO; GO:0010587; P:miRNA catabolic process; IDA:WormBase.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0060965; P:negative regulation of gene silencing by miRNA; IMP:WormBase.
DR   GO; GO:0040034; P:regulation of development, heterochronic; IGI:WormBase.
DR   GO; GO:0040028; P:regulation of vulval development; IGI:WormBase.
DR   InterPro; IPR027073; 5_3_exoribonuclease.
DR   InterPro; IPR004859; Put_53exo.
DR   InterPro; IPR017151; Xrn2/3/4.
DR   PANTHER; PTHR12341; PTHR12341; 1.
DR   Pfam; PF03159; XRN_N; 1.
DR   PIRSF; PIRSF037239; Exonuclease_Xrn2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Developmental protein; Exonuclease;
KW   Hydrolase; Metal-binding; mRNA processing; Nuclease; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Transcription termination; Zinc; Zinc-finger.
FT   CHAIN         1    975       5'-3' exoribonuclease 2 homolog.
FT                                /FTId=PRO_0000249916.
FT   ZN_FING     262    279       CCHC-type.
FT   REGION      534    787       Interaction with paxt-1.
FT                                {ECO:0000269|PubMed:24462208,
FT                                ECO:0000269|PubMed:26779609}.
FT   MUTAGEN     234    236       DAD->AAA: Abolishes catalytic activity.
FT                                {ECO:0000269|PubMed:24462208}.
FT   HELIX         5     13       {ECO:0000244|PDB:5FIR}.
FT   HELIX        15     17       {ECO:0000244|PDB:5FIR}.
FT   STRAND       18     20       {ECO:0000244|PDB:5FIR}.
FT   STRAND       43     46       {ECO:0000244|PDB:5FIR}.
FT   STRAND       48     54       {ECO:0000244|PDB:5FIR}.
FT   HELIX        56     63       {ECO:0000244|PDB:5FIR}.
FT   STRAND       66     68       {ECO:0000244|PDB:5FIR}.
FT   HELIX        74     92       {ECO:0000244|PDB:5FIR}.
FT   STRAND       94    101       {ECO:0000244|PDB:5FIR}.
FT   HELIX       108    142       {ECO:0000244|PDB:5FIR}.
FT   HELIX       158    160       {ECO:0000244|PDB:5FIR}.
FT   HELIX       166    185       {ECO:0000244|PDB:5FIR}.
FT   HELIX       187    191       {ECO:0000244|PDB:5FIR}.
FT   STRAND      193    197       {ECO:0000244|PDB:5FIR}.
FT   HELIX       205    217       {ECO:0000244|PDB:5FIR}.
FT   STRAND      227    231       {ECO:0000244|PDB:5FIR}.
FT   HELIX       236    243       {ECO:0000244|PDB:5FIR}.
FT   STRAND      247    254       {ECO:0000244|PDB:5FIR}.
FT   STRAND      300    304       {ECO:0000244|PDB:5FIR}.
FT   HELIX       305    315       {ECO:0000244|PDB:5FIR}.
FT   HELIX       327    341       {ECO:0000244|PDB:5FIR}.
FT   HELIX       354    356       {ECO:0000244|PDB:5FIR}.
FT   HELIX       358    373       {ECO:0000244|PDB:5FIR}.
FT   STRAND      377    379       {ECO:0000244|PDB:5FIR}.
FT   HELIX       385    397       {ECO:0000244|PDB:5FIR}.
FT   HELIX       399    407       {ECO:0000244|PDB:5FIR}.
FT   STRAND      537    539       {ECO:0000244|PDB:5FIR}.
FT   HELIX       542    551       {ECO:0000244|PDB:5FIR}.
FT   HELIX       558    581       {ECO:0000244|PDB:5FIR}.
FT   HELIX       598    601       {ECO:0000244|PDB:5FIR}.
FT   HELIX       604    606       {ECO:0000244|PDB:5FIR}.
FT   HELIX       620    627       {ECO:0000244|PDB:5FIR}.
FT   HELIX       630    635       {ECO:0000244|PDB:5FIR}.
FT   HELIX       638    645       {ECO:0000244|PDB:5FIR}.
FT   HELIX       652    654       {ECO:0000244|PDB:5FIR}.
FT   HELIX       669    671       {ECO:0000244|PDB:5FIR}.
FT   STRAND      672    674       {ECO:0000244|PDB:5FIR}.
FT   HELIX       681    688       {ECO:0000244|PDB:5FIR}.
FT   HELIX       689    694       {ECO:0000244|PDB:5FIR}.
FT   HELIX       697    702       {ECO:0000244|PDB:5FIR}.
FT   STRAND      708    713       {ECO:0000244|PDB:5FIR}.
FT   HELIX       719    728       {ECO:0000244|PDB:5FIR}.
FT   HELIX       738    741       {ECO:0000244|PDB:5FIR}.
FT   STRAND      747    749       {ECO:0000244|PDB:5FIR}.
FT   STRAND      773    775       {ECO:0000244|PDB:5FIR}.
FT   STRAND      778    784       {ECO:0000244|PDB:5FIR}.
**
**   #################    INTERNAL SECTION    ##################
**DR PROSITE; PS50158; ZF_CCHC; FALSE_NEG.
**EV ECO:0000244; PDB:5FIR; HEB; 23-MAY-2016.
**EV ECO:0000269; PubMed:16122351; HEB; 31-MAY-2016.
**EV ECO:0000269; PubMed:19734881; HEB; 31-MAY-2016.
**EV ECO:0000269; PubMed:21397849; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:23541767; XXX; 01-JAN-1900.
**EV ECO:0000269; PubMed:24462208; HEB; 10-JUN-2016.
**EV ECO:0000269; PubMed:26779609; HEB; 09-JUN-2016.
**EV ECO:0000305; -; XXX; 01-JAN-1900.
**EV ECO:0000312; WormBase:Y48B6A.3; HEB; 20-MAY-2016.
**SO UPD; 77934; 14-JUN-2013.
**ZA ALB, 21-AUG-2006, Quick;
**ZB REF, 28-OCT-2008; GAC, 13-AUG-2013; HEB, 06-JUL-2016;
SQ   SEQUENCE   975 AA;  110128 MW;  219234BA731ABCF6 CRC64;
     MGVPAFFRWL TKKYPATVVN ANEDRQRDQD GNRVPVDCTQ PNPNFQEFDN LYLDMNGIIH
     PCTHPEDRPA PKNEDEMFAL IFEYIDRIYS IVRPRRLLYM AIDGVAPRAK MNQQRSRRFR
     ASKEMAEKEA SIEEQRNRLM AEGIAVPPKK KEEAHFDSNC ITPGTPFMAR LADALRYYIH
     DRVTNDASWA NIEIILSDAN VPGEGEHKIM DYVRKQRGNP AHDPNTVHCL CGADADLIML
     GIATHEANFN IIREEFVPNQ PRACDLCGQY GHELKECRGA ENETDLGDDY CKPEQREKNF
     IFLRIPVLRE YLEKELSMPN LPFKFDVERA LDDWVFLCFF VGNDFLPHLP SLEIREGAID
     RLIKLYKEMV YQMKGYLTKD GIPELDRVEM IMKGLGRVED EIFKRRQQDE ERFQENQRNK
     KARMQMYGGG GRGGRGRGRG RGQQPAFVPT HGILAPMAAP MHHSGESTRQ MASEARQTAM
     KFTNDANETA AANLKALLNV KGEESPADIA SRKRKAEQPL IKPEEEEDEG PKDDIRLYES
     GWKDRYYRAK FDVGSDDIEF RHRVAWAYVE GLCWVLRYYY QGCASWDWYF PYHYAPFASD
     FETVGEFQPD FTRPTKPFNP LEQLMSVFPA ASKQHLPVEW QKLMIQDDSP IIDLYPADFR
     IDLNGKKYAW QGVALLPFVD ETRLLATLQS VYPTLTAEEK QRNTRGPNRI FIGRNHKSFE
     FFQQVAESKS DDLVPLDPTL LNGVSGKIAY DSTATAPGLP FVSPVNHDEC QDLPTNCGIC
     VLYEDPEYPQ DYIFPALRLD GAKEPEKTLK PDDWNDRRDG RYQPQVGFNR NAPRGSLDQS
     GHRQVHHYVR GGGGGGGGYR GNSYDDRRGG GGGGGGYNDR QDFGRNYGGR DGGGPQRYHD
     QQQQRQGGYQ GGGYGGGYGG GGGGGGGGGG GSYHQPYNQD QRRGGRGGGG GPPGYQRPPY
     RGGGGGGYHG NSSWR
//
